Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Jinbikang Pharmaceutical Technology Co., Ltd. is a specialized pharmaceutical company based in Hangzhou, China, that focuses on the research, development, and manufacturing of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Established in 2016, the company leverages its expertise in chemical synthesis to support the development of high-quality generic medications and innovative drug candidates. Their business model encompasses technical consulting, technology transfer, and the production of specialized chemical entities for the global life sciences industry. Jinbikang is particularly active in the fields of cardiovascular health and metabolic disorders, providing essential components for various therapeutic formulations. The company maintains a strong emphasis on regulatory compliance and advanced process chemistry to ensure the efficiency and safety of its products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 浙江金必康医药科技.